| 📰 Ministry of Health, Labour and Welfare Press Release

183rd Medical Verification Working Group

SUMMARY

According to reports from the Ministry of Health, Labour and Welfare's press releases, the "183rd Medical Verification Working Group" has been announced. As a recent development in the medical industry, this information is valuable for the management decisions of hospitals, clinics, and medical corporations.

📝 EDITOR'S NOTE — A Medical M&A Perspective

Trends in the medical industry directly impact the succession and M&A strategies of hospitals, clinics, and medical corporations. Changes in the complex management environment, such as revisions to medical fees, lack of successors, staffing shortages, burden of capital investment, and progress in regional medical plans, are forcing medical institutions to make new management decisions.

As an option for successor issues and changes in the management environment,Third-Party Succession M&Ais increasing in importance year by year. Choosing succession over closure or廃業 (business dissolution) allows for the simultaneous achievement of securing a transfer price, maintaining staff employment, ensuring continuity of patient care, and preserving regional medical services. The framework of M&A support institutions certified by the Small and Medium Enterprise Agency has also been established, and advisory services specializing in the unique licensing, tax, and labor issues of the medical industry have become widespread.

For medical institutions, accurately grasping industry trends and seeking early consultation with experts are key to attracting the best options for management decisions. As an M&A advisory firm specializing in the medical industry, we support medical institutions with free consultations and success-fee-based services.

News Highlights

An overview of the 183rd Medical Verification Working Group meeting. This group emphasizes the value of choosing third-party succession as a countermeasure to successor issues in the management of medical institutions, rather than closure or廃業 (haigyō – business closure/liquidation). It particularly stresses the importance of early preparation in 5-10 year increments starting around age 60 for chairpersons and directors, and recommends utilizing specialized advisors focused on the healthcare industry.

M&A Medical Editorial Department’s Perspective

The discussions at the 183rd Medical Verification Working Group once again suggest the effectiveness of “third-party succession” in business succession for medical institutions. Third-party succession has significant potential not only as a solution for a lack of successors but also for avoiding closure or 廃業 (haigyō – business closure/liquidation) and ensuring the continuity of regional medical care. The point that chairpersons and directors should start preparations on a long-term basis of 5 to 10 years from around age 60 is particularly indicative of the importance of executing planned M&A. This emphasizes the significance of not just finding a buyer, but also having sufficient time to organize one’s own institution’s strengths and envision its future. The utilization of industry-specific advisors can be considered indispensable for constructing more precise schemes based on specialized knowledge, networks, and experience with similar cases.

Points Raised by This News

  • Third-party succession is a viable alternative to closure or 廃業 (haigyō – business closure/liquidation) for maintaining the continuity of regional medical care.
  • It is essential for chairpersons and directors to start business succession planning early, in 5-10 year increments, from around age 60.
  • Utilizing industry-specific professional advisors is effective for the business succession of medical institutions.
  • Preparation with a long-term perspective leads to organizing the institution’s strengths and formulating a future vision.

Practical Questions Arising from This News

  • Specifically, what kind of medical institutions are suitable for third-party succession?
  • When starting preparations for business succession around age 60, what specific steps should be taken?
  • What specific services do advisors specializing in medical institutions provide?

If You Feel “Should I Consult Too?”

Considering the age of your institution’s chairperson/director, are you concretely considering future business succession? With third-party succession gaining attention as an option other than closure or 廃業 (haigyō – business closure/liquidation), early planning involving specialists is crucial to continue contributing to regional medical care. If you are feeling anxious about a lack of successors or the future vision of your management, we recommend consulting with a specialist in medical M&A. You will likely discover the optimal path tailored to your institution’s situation.

Sponsored Links

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics with a complete success-fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are kept strictly confidential. Free consultations are available here.

Related Sponsors

📌 Source (Primary Information)

183rd Medical Verification Working Group

Source: Ministry of Health, Labour and Welfare Press Releases

Please see the original article for details

Regarding trends in medical institutions like this case,

we provide a detailed explanation of the 'Medical Succession Guide'

Read the Complete Guide →

📚 Related Medical Succession Columns

For medical succession consultations, contact M&A Medical

Strict confidentiality, free initial consultation, success-based fee.

Apply for a Free Consultation